Published in
Taylor and Francis Group, Leukemia & Lymphoma, 8(61), p. 1823-1832, 2020
DOI: 10.1080/10428194.2020.1788015
Links
Tools
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis
Journal article published in 2020 by
María Laura Fox 
,
Irene García-Cadenas ,
Ariadna Martínez Pérez,
Guillermo Villacampa ,
José Luis Piñana ,
Guillermo Ortí ,
Juan Montoro ,
Elisa Roldán ,
Anna Bosch Vilaseca,
Rodrigo Martino ,
Olga Salamero ,
Silvana Saavedra,
Juan Carlos Hernandez-Boluda ,
Albert Esquirol ,
Jordi Sierra
and other authors.
,
Irene García-Cadenas ,
Ariadna Martínez Pérez,
Guillermo Villacampa ,
José Luis Piñana ,
Guillermo Ortí ,
Juan Montoro ,
Elisa Roldán ,
Anna Bosch Vilaseca,
Rodrigo Martino ,
Olga Salamero ,
Silvana Saavedra,
Juan Carlos Hernandez-Boluda ,
Albert Esquirol ,
Jordi Sierra
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 